Adjuvant therapy shows promise in biliary tract cancer

Adjuvant therapy shows promise in biliary tract cancer
(HealthDay) -- For patients with biliary tract cancers, postresection adjuvant therapy with chemotherapy or chemoradiotherapy appears to be beneficial in treating patients with biliary tract cancers, with significant improvement seen for patients with node or margin positivity, according to research published online April 23 in the Journal of Clinical Oncology.

Anne M. Horgan, M.D., of the Princess Margaret Hospital in Toronto, and colleagues conducted a systematic review and meta-analysis of 20 studies involving 6,712 patients to study the impact of adjuvant therapy on the survival of patients with biliary tract cancer.

Compared with surgery alone, the researchers found that adjuvant therapy was associated with a nonsignificant improvement in overall survival (pooled odds ratio [OR], 0.74; P = 0.06). No survival difference was observed for patients with bile duct tumors or (P = 0.68). Adjuvant chemotherapy or chemotherapy plus offered significantly improved survival compared with radiation therapy alone (OR, 0.39, 0.61, 0.98, respectively; P = 0.02). Adjuvant therapy was most effective in patients with lymph-node positive disease (OR, 0.49; P = 0.004) or resection margin positivity (OR, 0.36; P = 0.002).

"The pooled analysis indicated nonsignificant benefit for adjuvant therapy in unselected patients," the authors write. "However, in subgroups with high-risk patients, such as those with node or margin positivity, postresection adjuvant therapy seems beneficial."


Explore further

Adjuvant therapy perhaps not necessary for older breast cancer patients

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: Journal of Clinical Oncology

Copyright © 2012 HealthDay. All rights reserved.

Citation: Adjuvant therapy shows promise in biliary tract cancer (2012, April 27) retrieved 24 June 2019 from https://medicalxpress.com/news/2012-04-adjuvant-therapy-biliary-tract-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more